It worked! As a result of your and AAPA’s advocacy efforts, the Senate HELP Committee will consider legislation tomorrow that will permit PAs and NPs to prescribe buprenorphine for the treatment of opioid addiction.
The amended TREAT Act (S. 1455) does not include a demonstration program. It amends federal law to
affirmatively authorize PAs to prescribe buprenorphine, treating PAs, NPs, and physicians in the same
manner, while deferring to State law.
Before receiving a waiver to prescribe buprenorphine for the treatment of opioid addiction,
all qualified providers (PAs, NPs, and physicians) must complete 24 hours of training in the treatment and
management of opiate-dependent patients. AAPA is listed as one of the organizations who can provide
the training. Additionally, the Senate HELP Committee will consider Mental Health Reform legislation, which recognizes the interface between primary care and behavioral healthcare, as well as the critical role of PAs in behavioral healthcare through the following provisions:
*Includes PAs in the mental health career development strategic plan
*Acknowledges PAs among the healthcare providers who may serve on mental health/substance abuse advisory councils established through the legislation
*Identifies PAs with experience treating serious mental illness as potential members of a new Inter-Departmental Serious Mental Illness Coordinating Committee
*Adds PAs in the development of model programs and materials for training healthcare providers on appropriate disclosures to family, friends, or other caregivers of individuals suffering from mental illness or substance abuse disorders.
Again, thank you. Your advocacy made a difference. We look forward to continuing to work with you as this important legislation progresses.
Should you have any additional questions, comments or concerns please contact Sandy directly at firstname.lastname@example.org .